Switch theme
Sign up to access all valuation multiples
Apollo Hospitals Enterprise Ltd operates a network of private hospitals in India through primary, secondary, and tertiary care facilities. The firm's tertiary care hospitals provide complex care in a variety of specialties that include cardiology, oncology, neuroscience, orthopedics, radiology, and gastroenterology. Apollo Hospitals also operates primary care and diagnostics clinics as well as telemedicine units and offers consulting, health insurance, education and training, and research services. Its reportable operating segments are; Healthcare Services (represents hospitals and hospitals services); Retail Health and Diagnostics (includes clinics and diagnostics); Digital Health and Pharmacy Distribution; and Others. Maximum revenue is generated from its Healthcare Services segment.
1979
18.7K+
LTM Revenue $2.6B
LTM EBITDA $373M
$13.2B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Apollo Hospitals has a last 12-month revenue (LTM) of $2.6B and a last 12-month EBITDA of $373M.
In the most recent fiscal year, Apollo Hospitals achieved revenue of $2.5B and an EBITDA of $379M.
Apollo Hospitals expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Apollo Hospitals valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $2.6B | XXX | $2.5B | XXX | XXX | XXX |
| Gross Profit | $1.3B | XXX | $1.2B | XXX | XXX | XXX |
| Gross Margin | 48% | XXX | 48% | XXX | XXX | XXX |
| EBITDA | $373M | XXX | $379M | XXX | XXX | XXX |
| EBITDA Margin | 14% | XXX | 15% | XXX | XXX | XXX |
| EBIT | $287M | XXX | $263M | XXX | XXX | XXX |
| EBIT Margin | 11% | XXX | 10% | XXX | XXX | XXX |
| Net Profit | $181M | XXX | $168M | XXX | XXX | XXX |
| Net Margin | 7% | XXX | 7% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $546M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 4, 2025, Apollo Hospitals's stock price is INR 7553 (or $88).
Apollo Hospitals has current market cap of INR 1.09T (or $12.6B), and EV of INR 1.13T (or $13.2B).
See Apollo Hospitals trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $13.2B | $12.6B | XXX | XXX | XXX | XXX | $1.23 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 4, 2025, Apollo Hospitals has market cap of $12.6B and EV of $13.2B.
Apollo Hospitals's trades at 5.4x EV/Revenue multiple, and 37.3x EV/EBITDA.
Equity research analysts estimate Apollo Hospitals's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Apollo Hospitals has a P/E ratio of 69.7x.
See valuation multiples for Apollo Hospitals and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $12.6B | XXX | $12.6B | XXX | XXX | XXX |
| EV (current) | $13.2B | XXX | $13.2B | XXX | XXX | XXX |
| EV/Revenue | 5.0x | XXX | 5.4x | XXX | XXX | XXX |
| EV/EBITDA | 35.4x | XXX | 37.3x | XXX | XXX | XXX |
| EV/EBIT | 46.1x | XXX | 53.4x | XXX | XXX | XXX |
| EV/Gross Profit | 10.4x | XXX | n/a | XXX | XXX | XXX |
| P/E | 69.7x | XXX | 83.0x | XXX | XXX | XXX |
| EV/FCF | 236.4x | XXX | 221.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialApollo Hospitals's last 12 month revenue growth is 17%
Apollo Hospitals's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Apollo Hospitals's rule of 40 is 32% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Apollo Hospitals's rule of X is 57% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Apollo Hospitals and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 17% | XXX | 18% | XXX | XXX | XXX |
| EBITDA Margin | 14% | XXX | 14% | XXX | XXX | XXX |
| EBITDA Growth | 24% | XXX | 20% | XXX | XXX | XXX |
| Rule of 40 | 32% | XXX | 32% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 57% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 38% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Apollo Hospitals acquired XXX companies to date.
Last acquisition by Apollo Hospitals was XXXXXXXX, XXXXX XXXXX XXXXXX . Apollo Hospitals acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Apollo Hospitals founded? | Apollo Hospitals was founded in 1979. |
| Where is Apollo Hospitals headquartered? | Apollo Hospitals is headquartered in India. |
| How many employees does Apollo Hospitals have? | As of today, Apollo Hospitals has 18.7K+ employees. |
| Is Apollo Hospitals publicy listed? | Yes, Apollo Hospitals is a public company listed on NSE. |
| What is the stock symbol of Apollo Hospitals? | Apollo Hospitals trades under APOLLOHOSP ticker. |
| When did Apollo Hospitals go public? | Apollo Hospitals went public in 1996. |
| Who are competitors of Apollo Hospitals? | Similar companies to Apollo Hospitals include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Apollo Hospitals? | Apollo Hospitals's current market cap is $12.6B |
| What is the current revenue of Apollo Hospitals? | Apollo Hospitals's last 12 months revenue is $2.6B. |
| What is the current revenue growth of Apollo Hospitals? | Apollo Hospitals revenue growth (NTM/LTM) is 17%. |
| What is the current EV/Revenue multiple of Apollo Hospitals? | Current revenue multiple of Apollo Hospitals is 5.0x. |
| Is Apollo Hospitals profitable? | Yes, Apollo Hospitals is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Apollo Hospitals? | Apollo Hospitals's last 12 months EBITDA is $373M. |
| What is Apollo Hospitals's EBITDA margin? | Apollo Hospitals's last 12 months EBITDA margin is 14%. |
| What is the current EV/EBITDA multiple of Apollo Hospitals? | Current EBITDA multiple of Apollo Hospitals is 35.4x. |
| What is the current FCF of Apollo Hospitals? | Apollo Hospitals's last 12 months FCF is $55.8M. |
| What is Apollo Hospitals's FCF margin? | Apollo Hospitals's last 12 months FCF margin is 2%. |
| What is the current EV/FCF multiple of Apollo Hospitals? | Current FCF multiple of Apollo Hospitals is 236.4x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
